Introduction: Strategies and Realities
The term ‘antisense’ has entered the popular vocabulary as a term denoting a novel approach to chemotherapy. The field that is encompassed by this term has blossomed to such an extent that it has now reached the stage of popularization (Chase, 1988; Kolata, 1988). But the basis for this approach, and the many assumptions and pitfalls involved in it, cannot be dealt with in a limited popular treatment.
Unable to display preview. Download preview PDF.
- Cazenave, C., Stein, C. A., Loreau, N., Thuong, N. T., Neckers, L. M., Subasinghe, C., Hélène, C., Cohen, J. S. and Toulmé, J.-J. (1989). Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides (submitted)Google Scholar
- Chase, M. (1988). Promise seen in ‘antisense’ medicine. Wall Street Journal, 22 AugustGoogle Scholar
- Eckstein, F. (1985). Investigation of enzyme mechanisms with nucleoside phosphorothioates. Anal. Biochem., 54, 367–402Google Scholar
- Kolata, G. (1988). Cancer researchers seek a genetics strategy. New York Times, 19 AprilGoogle Scholar
- Melton, D. A. (Ed.) (1988). Antisense RNA and DNA, Cold Spring HarborGoogle Scholar